au.\*:("CHRISTENSEN, Lise")
Results 1 to 25 of 41
Selection :
The distribution of fibronectin laminin and tetranectin in human breast cancer with special attention to the extracellular matrixCHRISTENSEN, Lise.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1992, Vol 100, issn 0903-4641, 39 p., SUP26Serial Issue
Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40DAUGAARD, SØren; CHRISTENSEN, Lise H; HØGDALL, Estrid et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2009, Vol 117, Num 7, pp 518-525, issn 0903-4641, 8 p.Article
Normal and Pathologic Tissue Reactions to Soft Tissue Gel FillersCHRISTENSEN, Lise.Dermatologic surgery. 2007, Vol 33, Num 2, issn 1076-0512, S168-S175, NSArticle
Host Tissue Interaction, Fate, and Risks of Degradable and Nondegradable Gel FillersHANNE CHRISTENSEN, Lise.Dermatologic surgery. 2009, Vol 35, Num 2, pp 1612-1619, issn 1076-0512, 8 p., NSArticle
Improved detection methods for infected hip joint prosthesesHØGDALL, Dan; HVOLRIS, JØrgen Jesper; CHRISTENSEN, Lise et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2010, Vol 118, Num 11, pp 815-823, issn 0903-4641, 9 p.Article
Persistence of a Salmonella enterica serovar Typhimurium DT12 clone in a piggery and in agricultural soil amended with salmonella-contaminated slurryBALODA, Suraj B; CHRISTENSEN, Lise; TRAJCEVSKA, Silvija et al.Applied and environmental microbiology (Print). 2001, Vol 67, Num 6, pp 2859-2862, issn 0099-2240Article
Bacterial Infection as a Likely Cause of Adverse Reactions to Polyacrylamide Hydrogel Fillers in Cosmetic SurgeryCHRISTENSEN, Lise; BREITING, Vibeke; BJARNSHOLT, Thomas et al.Clinical infectious diseases. 2013, Vol 56, Num 10, pp 1438-1444, issn 1058-4838, 7 p.Article
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients : From the 'MALOVA' Ovarian Cancer StudyHOGDALL, Estrid V. S; CHRISTENSEN, Lise; HOGDALL, Claus K et al.Oncology reports. 2007, Vol 18, Num 5, pp 1051-1059, issn 1021-335X, 9 p.Article
Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer StudyHØGDALL, Estrid V. S; CHRISTENSEN, Lise; KJAER, Susanne K et al.Cancer. 2003, Vol 98, Num 1, pp 66-73, issn 0008-543X, 8 p.Article
Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer studyHØGDALL, Estrid V. S; CHRISTENSEN, Lise; KJAER, Susanne K et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2010, Vol 118, Num 8, pp 557-564, issn 0903-4641, 8 p.Article
Primary mucinous carcinoma of the skin : a population-based studyBREITING, Line; CHRISTENSEN, Lise; DAHLSTRØM, Karin et al.International journal of dermatology. 2008, Vol 47, Num 3, pp 242-245, issn 0011-9059, 4 p.Article
Hormone therapy and the impact of estrogen intake on the risk of ovarian cancerGLUD, Eva; KJAER, Susanne K; THOMSEN, Birthe L et al.Archives of internal medicine (1960). 2004, Vol 164, Num 20, pp 2253-2259, issn 0003-9926, 7 p.Article
Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer studyHEERAN, Mel C; HØGDALL, Claus K; KJAER, Susanne K et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2012, Vol 120, Num 10, pp 846-854, issn 0903-4641, 9 p.Article
Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma studyHØGDALL, Estrid V. S; RYAN, Andy; KJAER, Susanne K et al.Cancer. 2004, Vol 100, Num 11, pp 2387-2395, issn 0008-543X, 9 p.Article
P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosisHØGDALL, Estrid Vs; HØGDALL, Claus K; BLAAKAER, Jan et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2002, Vol 110, Num 7-8, pp 545-553, issn 0903-4641, 9 p.Article
Adverse reactions to injectable soft tissue fillersREQUENA, Luis; REQUENA, Celia; CHRISTENSEN, Lise et al.Journal of the American Academy of Dermatology. 2011, Vol 64, Num 1, pp 1-34, issn 0190-9622, 34 p.Article
The X-shooter pipelineMODIGLIANI, Andrea; GOLDONI, Paolo; KERBER, Florian et al.Proceedings of SPIE, the International Society for Optical Engineering. 2010, Vol 7737, issn 0277-786X, isbn 0-8194-8227-7 978-0-8194-8227-3, 1Vol, 773728.1-773728.12Conference Paper
Smoking and overweight : Negative prognostic factors in stage III epithelial ovarian cancerKJOERBYE-THYGESEN, Anette; FREDERIKSEN, Kirsten; HØGDALL, Estrid V et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 4, pp 798-803, issn 1055-9965, 6 p.Article
PMAS : The potsdam multi-aperture spectrophotometer. I. Design, manufacture, and performanceROTH, Martin M; KELZ, Andreas; POPOW, Emil et al.Publications of the Astronomical Society of the Pacific. 2005, Vol 117, Num 832, pp 620-642, issn 0004-6280, 23 p.Article
K-ras alterations in Danish ovarian tumour patients. From the Danish Malova Ovarian Cancer StudyHØGDALL, Estrid V. S; HØGDALL, Claus K; BLAAKAER, Jan et al.Gynecologic oncology (Print). 2003, Vol 89, Num 1, pp 31-36, issn 0090-8258, 6 p.Article
Serum tetranectin is a significant prognostic marker in ovarian cancer patientsBEGUM, Farah Diba; HØGDALL, Estrid; JARLE CHRISTENSEN, I B et al.Acta obstetricia et gynecologica scandinavica. 2010, Vol 89, Num 2, pp 190-198, issn 0001-6349, 9 p.Article
The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patientsFARAH DIBA BEGUM; HØGDALL, Claus K; KJAER, Susanne K et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1981-1985, issn 0250-7005, 5 p.Article
Evaluation of a polymorphism in intron 2 of the P53 gene in ovarian cancer patients. from the Danish Malova ovarian cancer studyHØGDALL, Estrid V. S; KJAER, Susanne K; GLUD, Eva et al.Anticancer research. 2003, Vol 23, Num 4, pp 3397-3404, issn 0250-7005, 8 p.Article
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survivalHØGDALL, Estrid V. S; JOHANSEN, Julia S; KJAER, Susanne K et al.Oncology reports. 2003, Vol 10, Num 5, pp 1535-1538, issn 1021-335X, 4 p.Article
Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patientsHØGDALL, Estrid V. S; HØGDALL, Claus K; CHRISTENSEN, Lise et al.Anticancer research. 2002, Vol 22, Num 3, pp 1859-1864, issn 0250-7005Article